-- 加拿大皇家銀行(RBC)表示,本週加拿大經濟數據發布相對平靜,市場的焦點集中在將於週三發布的2月製造業和批發貿易報告上。 加拿大統計局的初步數據顯示,2月剔除石油和農產品後的批發銷售額較上季成長2.3%,製造業銷售額較上季成長3.8%,主要得益於運輸子產業和食品加工品銷售額的成長。 該銀行指出,這兩項數據均與先前的報告一致,即去年底和2026年初汽車生產的中斷是暫時的。先前的中斷與部分工廠的半導體短缺有關,而1月的最新中斷則是由於部分工廠冬季改造時間比往年更長,以生產新車型。 加拿大皇家銀行表示,製造業和批發業的預期反彈表明,在經歷了年初的疲軟之後,2月份商品行業的成長勢頭將更加強勁。結合先前的數據,這些數據進一步強化了這樣一種觀點:在1月小幅成長之後,潛在的經濟活動正在逐步改善。 該銀行指出,在經濟服務領域,房屋二手房銷售持續承壓,3月的早期市場報告喜憂參半,此前自2025年10月以來,全國二手房銷售已連續四個月下滑。 早期報告顯示,部分市場(包括多倫多)的銷售量有所成長,但溫哥華的銷售仍在下滑。不列顛哥倫比亞省、阿爾伯塔省和安大略省的房價也持續小幅下跌,而魁北克省、草原省份部分地區和大西洋沿岸地區的房價則有所上漲。 加拿大皇家銀行補充道,整體而言,1月實際國內生產毛額季增0.1%,初步估計顯示2月將持續擴張,進而支撐第一季經濟成長回升。 總的來說,儘管各行業仍存在波動,但目前的數據與該銀行對第一季溫和成長且成長動能正在增強的基本預測基本一致。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.